CN104411704B - 制备三唑化合物的方法 - Google Patents

制备三唑化合物的方法 Download PDF

Info

Publication number
CN104411704B
CN104411704B CN201380036548.5A CN201380036548A CN104411704B CN 104411704 B CN104411704 B CN 104411704B CN 201380036548 A CN201380036548 A CN 201380036548A CN 104411704 B CN104411704 B CN 104411704B
Authority
CN
China
Prior art keywords
formula
compound
triazol
reaction
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201380036548.5A
Other languages
English (en)
Chinese (zh)
Other versions
CN104411704A (zh
Inventor
H-C.米利策尔
J.埃格特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48325714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN104411704(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of CN104411704A publication Critical patent/CN104411704A/zh
Application granted granted Critical
Publication of CN104411704B publication Critical patent/CN104411704B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CN201380036548.5A 2012-05-08 2013-05-06 制备三唑化合物的方法 Active CN104411704B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12167152.3 2012-05-08
EP12167152 2012-05-08
PCT/EP2013/059418 WO2013167552A1 (de) 2012-05-08 2013-05-06 Verfahren zur herstellung von triazol-verbindungen

Publications (2)

Publication Number Publication Date
CN104411704A CN104411704A (zh) 2015-03-11
CN104411704B true CN104411704B (zh) 2017-12-22

Family

ID=48325714

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380036548.5A Active CN104411704B (zh) 2012-05-08 2013-05-06 制备三唑化合物的方法

Country Status (35)

Country Link
US (1) US10301289B2 (https=)
EP (1) EP2847183B1 (https=)
JP (1) JP6149104B2 (https=)
KR (1) KR102086389B1 (https=)
CN (1) CN104411704B (https=)
AP (1) AP2014008089A0 (https=)
AU (1) AU2013258107B2 (https=)
BR (1) BR112014027564B1 (https=)
CA (1) CA2872726C (https=)
CL (2) CL2014003003A1 (https=)
CO (1) CO7121324A2 (https=)
CR (1) CR20140514A (https=)
CU (1) CU20140128A7 (https=)
DK (1) DK2847183T3 (https=)
DO (1) DOP2014000254A (https=)
EA (1) EA027804B1 (https=)
ES (1) ES2641205T3 (https=)
HR (1) HRP20171321T1 (https=)
HU (1) HUE034430T2 (https=)
IL (1) IL235441A (https=)
LT (1) LT2847183T (https=)
MX (1) MX350519B (https=)
MY (1) MY184577A (https=)
NZ (1) NZ701661A (https=)
PE (1) PE20142453A1 (https=)
PH (1) PH12014502482A1 (https=)
PL (1) PL2847183T3 (https=)
PT (1) PT2847183T (https=)
RS (1) RS56255B1 (https=)
SG (2) SG10201609319YA (https=)
SI (1) SI2847183T1 (https=)
TN (1) TN2014000469A1 (https=)
UA (1) UA116349C2 (https=)
WO (1) WO2013167552A1 (https=)
ZA (1) ZA201408571B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2639716B2 (ja) 1988-12-14 1997-08-13 横浜ゴム株式会社 タイヤ成形装置に於けるグリーンタイヤの搬送装置
JOP20170103A1 (ar) * 2016-05-03 2017-11-03 Bayer Pharma AG عملية لتحضير مشتقات 1-فنيل-1، 2، 4-تريازول مستبدلة بـ 5-هيدروكسي ألكيل
CN108084099B (zh) * 2017-12-20 2019-01-29 天驰药业有限公司 一种1,2,3-三氮唑化合物的合成方法
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents
EP3888684A1 (en) 2020-03-31 2021-10-06 Bayer Animal Health GmbH Composition having improved voluntary acceptance
JP7710897B2 (ja) * 2021-06-01 2025-07-22 三菱ガス化学ネクスト株式会社 1-アルキル-5-ヒドロキシピラゾールの製造方法
CN114264752B (zh) * 2021-12-29 2023-08-15 北京金城泰尔制药有限公司 溴乙酸甲酯的检测方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003101442A1 (en) * 2002-05-31 2003-12-11 Smithkline Beecham Corporation Peptide deformylase inhibitors
CN1871208A (zh) * 2003-10-30 2006-11-29 默克公司 作为大麻素受体调节剂的芳烷基胺
CN101631785A (zh) * 2006-10-26 2010-01-20 拜耳先灵制药股份公司 用于治疗心血管和血液病的取代的二氢吡唑啉酮

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135184A (da) 1983-03-03 1984-10-10 Riker Laboratories Inc Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
US4752910A (en) 1984-10-30 1988-06-21 Prime Computer, Inc. Method and apparatus for continuous after-imaging
CL2003002353A1 (es) 2002-11-15 2005-02-04 Vertex Pharma Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
US7745630B2 (en) 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
DE102008020113A1 (de) 2008-04-23 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituierte Dihydropyrazolone und ihre Verwendung
EP1877399A1 (en) 2005-04-26 2008-01-16 Pfizer Limited Triazole derivatives as vasopressin antagonists
CA2608718A1 (en) 2005-05-18 2006-11-23 Pfizer Limited 1, 2, 4-triazole derivatives as vasopressin antagonists
DE102010041236A1 (de) * 2010-09-23 2012-03-29 Osram Ag Optoelektronisches Halbleiterbauelement
DE102010044131A1 (de) * 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituiertes Natrium-1H-pyrazol-5-olat

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003101442A1 (en) * 2002-05-31 2003-12-11 Smithkline Beecham Corporation Peptide deformylase inhibitors
CN1871208A (zh) * 2003-10-30 2006-11-29 默克公司 作为大麻素受体调节剂的芳烷基胺
CN101631785A (zh) * 2006-10-26 2010-01-20 拜耳先灵制药股份公司 用于治疗心血管和血液病的取代的二氢吡唑啉酮

Also Published As

Publication number Publication date
JP2015516403A (ja) 2015-06-11
EP2847183B1 (de) 2017-06-21
CO7121324A2 (es) 2014-11-20
CR20140514A (es) 2014-12-02
LT2847183T (lt) 2017-09-25
CA2872726A1 (en) 2013-11-14
KR20150018534A (ko) 2015-02-23
SG10201609319YA (en) 2016-12-29
TN2014000469A1 (en) 2016-03-30
EA027804B1 (ru) 2017-09-29
WO2013167552A1 (de) 2013-11-14
CL2014003003A1 (es) 2015-02-13
IL235441A (en) 2017-09-28
ZA201408571B (en) 2016-03-30
HK1208027A1 (en) 2016-02-19
BR112014027564A2 (https=) 2017-08-22
PL2847183T3 (pl) 2017-11-30
JP6149104B2 (ja) 2017-06-14
PE20142453A1 (es) 2015-01-17
UA116349C2 (uk) 2018-03-12
KR102086389B1 (ko) 2020-03-09
RS56255B1 (sr) 2017-11-30
HRP20171321T1 (hr) 2017-10-20
MX350519B (es) 2017-09-08
US20150087827A1 (en) 2015-03-26
SI2847183T1 (sl) 2017-10-30
DK2847183T3 (en) 2017-10-02
NZ701661A (en) 2016-08-26
PH12014502482A1 (en) 2015-01-12
CN104411704A (zh) 2015-03-11
SG11201407043PA (en) 2014-12-30
AP2014008089A0 (en) 2014-11-30
MY184577A (en) 2021-04-06
CL2016001165A1 (es) 2016-12-02
HUE034430T2 (en) 2018-02-28
AU2013258107A1 (en) 2014-11-27
MX2014013448A (es) 2014-12-08
ES2641205T3 (es) 2017-11-08
US10301289B2 (en) 2019-05-28
PT2847183T (pt) 2017-10-02
AU2013258107B2 (en) 2017-06-22
DOP2014000254A (es) 2016-01-31
EP2847183A1 (de) 2015-03-18
BR112014027564B1 (pt) 2022-05-03
EA201492032A1 (ru) 2015-04-30
CA2872726C (en) 2020-07-07
CU20140128A7 (es) 2015-03-30

Similar Documents

Publication Publication Date Title
CN104411704B (zh) 制备三唑化合物的方法
JP7769066B2 (ja) (s)-5-アミノ-3-(4-((5-フルオロ-2-メトキシベンズアミド)メチル)フェニル)-1-(1,1,1-トリフルオロプロパン-2-イル)-1h-ピラゾール-4-カルボキサミドの製造方法及び中間体
EP2018372B1 (en) Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor
CA2948763C (en) Process for making benzoxazepin compounds
RS52988B (sr) Trans-4-[[(5s)-5-[[[3,5-bis(trifluormetil)fenil]metil](2-metil-2h-tetrazol-5-il)amino]-2,3,4,5-tetrahidro-7,9-dimetil-1h-1-benzazepin-1-il]metil]-cikloheksankarboksilna kiselina
CN107074776A (zh) Copanlisib及其二盐酸盐的合成
CN110612291B (zh) 2-([1,2,3]三唑-2-基)-苯甲酸衍生物的制备
WO2011113789A1 (en) Process for preparing alkyl 2-alkoxymethylene-4,4-difluoro-3-oxobutyrates
CN103224498B (zh) 两种唑并喹唑啉酮稠杂环的新合成方法
DK2571854T3 (en) PROCESS FOR THE PREPARATION OF 1-alkyl-3-difluoromethyl-5-hydroxypyrazoles
JP4238978B2 (ja) ベンゾアゼピン化合物及びその製造法
KR20160079560A (ko) 피롤 유도체 및 이의 제조 방법
HK1208027B (en) Method for the preparation of triazole compounds
JP4126944B2 (ja) 5−アミノ−4−ニトロソピラゾール化合物の製法
WO2007090464A1 (en) Process for preparing letrozole
JPS6112675A (ja) ピリミジン誘導体
JPH0466572A (ja) N―アルキルピラゾール誘導体の製法
HK1121453B (en) Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1208027

Country of ref document: HK

GR01 Patent grant
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1208027

Country of ref document: HK